PME Endocrine System Flashcards
sulfonylureas
- oral hypoglycemics
- first oral hypoglycemic class used to treat Type 2 DM
- prototype: glipizide
- 2nd gen
- stronger than 1st gen
- other: tolbutamide (1st gen)
sulfonylurea drug mechanism of action
- stimulates release of insulin from pancreatic islet cells
- pt must have functioning pancreas
- insulin release related to blood glucose level, so hypoglycemia not usually a problem
side effects of sulfonylureas
- mild hypoglycemia
- in pts with impaired liver or kidney function
- slower metabolism and excretion of drug → prolonged action
- nausea
- diarrhea
s/sx of hypoglycemia
- diaphoresis
- tachycardia
- fatigue
- excessive hunger
- tremors
- BG level < 70
Tx of mild hypoglycemia
- give 15-20 g carbohydrate
- if conscious, give oral, pill or food
- 4 oz fruit juice
- 6 saltines
- 1 Tbsp honey
- if unconscious, give parenterally
- IV glucose if access available
- 1 mg glucagon SQ or IM
- check BG every 15 min until
- level is in reference range
- Sx resolved
administration of glipizide
- give orally 30 min before selected meals
- swallow sustained-release form whole
- pregnancy: stop taking 48 hr before delivery
pt education for hypoglycemia and sulfonylureas
- wear medical alert bracelet
- watch for a report sx of hypoglycemia and recurrent hypoglycemic episodes
- test BG to confirm
- eat 15-20 g carbs
- retest in 15-20 min
- repeat Tx if needed
- carry carb snack at all times
- nausea: lie down
- eat adequate carbs
contraindications and precautions for sulfonylureas
- contra
- pregnancy
- lactation
- DKA
- caution
- thyroid dz
- renal or hepatic dysfunction
- adrenal or pituitary insufficiency
interactions with sulfonylureas
- alcohol
- N&V
- palpitations
- flushing
- increased effects
- sulfonamide abx
- NSAIDs
- oral anticoagulants
- salicylates
- MOAIs
- cimetidine
- thiazides counteract
- beta blockers mask hypoglycemia sx (tachycardia)
meglitinides
- for Type 2 DM
- prototype: repaglinide
- other: nateglinide
mechanism of action for meglitinides
- stimulate release of insuline from islet cells
- must have functioning pancreas
- insulin release related to BG level
- wont’ work for pts who don’t respond to sulfonylureas
- severe hypoglycemia not usually a problem
side effects of meglitinides
- mild hypoglycemia: more common in pts with impaired liver function
- nausea
- diarrhea
- notify provider of persistent nausea, vomiting, or diarrhea
administering repaglinide
- take orally 30 min or less before meal, usually 3x daily
- skip dose if skipping meal
- add dose if adding meal
- do not exceed 4 doses/day
contraindications and precautions for meglitinides
- contra
- DKA
- caution
- older adults
- renal or hepatic dysfunction
- systemic infection
interactions with meglitinides
- ↑ hypoglycemic effects
- gemfibrozil
- erythromycin
- ketoconazole
- grapefruit juice (> 1 L/day)
- ginseng
- garlic
- counteract
- barbituates
- carbamazepine
- rifampin
biguanides
- oral hypoglycemics
- Tx for Type 2 DM
- usually 1st drug Rx for newly diagnosed
- prototype (only drug in class): metformin
- can be combined with other oral hypoglycemics
- glipizide
- repaglinide
mechanism of action for metformin (biguanide)
- lowers BG in 3 ways
- ↓ absorption from intestines
- ↓ synthesis of glucose in liver
- ↑ sensitivity of insulin receptors
- different MOA from sulfonylureas and meglitinides
- provides better control in combination therapy
side effects of metformin
- can be severe
- nausea
- diarrhea
- anorexia
- vitamin deficiencies: can affect absorption; monitor levels
- B12
- folic acid
- lactic acidosis: rare, but potentially fatal
- r/t effect on mitochondrial oxidation of lactic acid
s/sx of lactic acidosis
- weakness
- fatigue
- lethargy
- hyperventilation
Tx for lactic acidosis
- stop metformin immediately
- draw labs to test for acidosis
- hemodialysis may be needed
administering metformin
- monitor
- fluid I/O
- for persistent nausea, vomiting, or diarrhea
- B12 or folic acid levels (recommend supplement)
- immediate-release: 2x/day with morning and evening meals
- extended-release: daily with evening meal; swallow whole
pt education for metformin
- lactic acidosis
- avoid alcohol
- report weakness, fatigue, lethargy, hyperventilation
- stop taking and seek medical care if sx develop
- GI problems
- expect effects to ↓
- lie down for nausea
- ensure adequate carb, clear fluid intake
- vitamin deficiency
- report weakness, fatigue, pallor, or red tongue
contraindications and precautions for metformin
- contra: ↑ risk of lactic acidosis
- DKA
- cardiopulmonary, hepatic, or renal insufficiency
- alcoholism
- heart failure
- severe infection
- shock
- acute MI
- hypoxemia
- lactic acidosis
- caution
- older adults
- diarrhea
- dehydration
- anemia
- gastroparesis
- pituitary insufficiency
- hypothyroidism
- GI obstruction
- PCOS
interactions with metformin
- ↑ risk of lactic acidosis
- alcohol
- cimetidine
- ↑ risk renal failure → lactic acidosis
- contrast medium with iodine
- ↑ hypoglycemic effects
- garlic
- ginseng
- captopril
- nifedipine
- furosemide
- morphine
- ranitidine
- antifungals
- many others
thiazolidinediones (glitazones)
- Tx for Type 2 DM
- with or without insuline or metformin
- prototype: pioglitazone
mechanism of action for glitazones
- reduce insulin resistance
- insulin must be available
- concurrent admin of metformin, a sulfonylurea, or insulin may be needed
side effects of glitazones
- fluid retention
- hepatotoxicity
- increased serum lipid levels
administration of glitazones
- monitor
- edema
- weight gain
- indications of heart failure
- serum ALT levels: baseline, every 3-6 mos after
- ↑ serum triglyceride, HDL, LDL levels
- stop drug for indications of liver injury
- report to provider
- swelling
- SOB
- wt gain > 2-3 kg
- indications of liver injury
- ↑ LDLs, triglycerides
- give orally once daily with or without food
glitazone patient education
- report
- immediately, significant change
- SOB
- wt gain
- swelling
- jaundice
- dark urine
- abd pain
- vomiting
- fatigue
- chest pain or discomfort
- diaphoresis
- immediately, significant change
- expect
- period cholesterol testing
- some swelling and wt gain
contraindications and precautions for glitazones
- contra
- CV dz, including HTN
- heart failure
- active hepatic dz
- caution
- mild heart failure
- hx of heart failure
- hepatic impairment
interactions with pioglitazone
- ↑ risk of heart failure, edema
- insulin
- ↑ hypoglycemic effects
- gemfibrozil
- ketoconazole
- green tea
- ginseng
- garlic
short name for thiazolidinediones
glitazones
alpha-glucosidase inhibitors (AGIs)
- Tx for Type 2 DM
- with or without insulin, sulfonylurea, or metformin
- prototype: acarbose
- other: miglitol
mechanism of action for AGIs
- block action of apha-glucosidase, an enzyme that breaks down carbs in intestine
- slows absorption of carbs after meal
- ↓ sudden postprandial BG ↑
side effects of AGIs
- GI: 2/2 fermentation of bacteria from carbs left in colon
- distention
- flatus
- hyperactive BS
- diarrhea
- hypoglycemia, in combo with sulfonylurea or insulin
- Tx difficult because absorption blocked
- give dextrose parenterally
- liver dysfunction and iron-deficiency anemia
- 2/2 long-term or high-dose use with carbose drug
- liver dysfunction reversible upon D/C of drug
administration of AGIs
- monitor
- GI sx: hyperactive BS, distention, diarrhea
- s/sx of hypoglycemia
- liver enzymes: baseline, every 3 mos for 1 yr, periodically after
- CBC (hgb), s/sx of anemia (pallor, fatigue)
- report
- persistent GI s/sx
- s/sx of liver injury
- Tx
- hypoglycemia: 4g dextrose
- liver injury: stop drug, report
- anemia: iron-rich foods, supplements
- give with first bite of food 3x/day
- skip dose if skipping meal, only take 1 dose at next meal
pt education for AGIs
- be aware of gastric SE; should ↓ over time
- follow diet recommended by provider
- wear medical alert bracelet
- watch for and report s/sx of hypoglycemia
- test BG to confirm
- take 4g of dextrose
- retest in 15 min
- repeat Tx if necessary
- carry dextrose tabs at all times
- report signs of
- liver dysfunction
- dark urine
- abd pain
- vomiting
- fatigue
- anemia
- pallor
- fatigue
- SOB
- liver dysfunction
contraindications and precautions for acarbose
- contra
- GI disorders (inflammatory bowel disease)
- GI obstruction
- GI ulceration
- caution
- hepatic impairment
- GI distress
interactions with AGIs
- ↑ risk of hypoglycemia
- insulin
- sulfonylureas
- ginseng
- ↑ GI effects
- metformin
- conteract
- estrogens
- thiazides
- corticosteroids
- phenothiazines
- isoniazid (INH)
- phenytoin
gliptins
- Tx for Type 2 DM
- with or without metformin or glitazone
- prototype (only drug, new class): sitagliptin
- also comes in combo with metformin
mechanism of action of sitagliptin
- augment endogenous incretin hormones by inhibiting enzyme that inactivates them
- promotes release of insulin
- ↓ secretion of glucagon
- ↓ fasting and postprandial BG
side effects of sitagliptin
- trials: small ↑ in
- URI
- inflammed nasal passages
- headache
- pancreatitis reported in post-release study, possible adverse effect
administration of gliptins
- monitor for
- respiratory sx
- body temp
- headaches (OTC analgesic if persistent)
- GI effects, s/sx of pancreatitis
- blood amylase level
- respiratory sx
- admin
- orally alone or as metformin combo
- with or without food
- ↓ dose for pts with severe renal impairment and low creatinine clearance
pt education for sitagliptin
- report
- persistent URI sx or fever
- persistent or uncontrolled headache
- severe upper abd pain
- abd pain that radiates to back and nausea or vomiting
contraindications and precautions for sitagliptin
- contra
- Type 1 DM
- lactic acidosis
- caution
- hemodialysis
- mod-severe renal dysfunction
- Hx of pancreatitis
interactions with sitagliptin
↑ digoxin levels (only known interaction)
injectable hypoglycemics
- insulin
- amylin mimetics
- incretin mimetics
Type 1 DM
- beta cells of pancreas become damaged and don’t produce insulin
- thought to be autoimmune
- oral hypoglycemics don’t work
- requires injectable hypoglycemics
insulin
- for Tx of
- DM (1 or 2) that can’t be controlled with oral hypoglycemics and diet
- gestational DM
- categorized by duration of action
- produced recombinant DNA tech
- prototypes
- rapid: lispro
- short: regular insulin (Humulin R)
- intermediate: NPH
- long: insulin glargine
- other
- rapid: insulin aspart
- short: regular insulin (Novolin R)
- intermediate: insulin detemir
- mixture: eliminates need to mix for pts who need multiple types
- short and intermediate: NPH 70% and regular 30% (Humulin 70/30)
- may be used to treat hyperkalemia
onset, peak, and duration times for rapid-acting lispro insulin
- onset: 15-30 min
- peak: 30 min to 2/5 hr
- duration: 3-6 hr
onset, peak, and duration times for short-acting regular insulin
- onset: 30 min to 1 hr
- peak: 1-5 hr
- duration: 6-10 hr
onset, peak, and duration times for NPH insulin
- onset: 1-2 hr
- peak: 6-14 hr
- duration: 16-24 hr
onset, peak, and duration times for insulin glargine
- onset: 70 min
- peak: none, steady levels
- duration: 24 hr
insulin produced by recombinant DNA technology
- chemically identical to insulin produced in beta cells
- promotes cellular uptake and use of glucose
- converts macronutrients
- glucose → glycogen
- amino acids → proteins
- fatty acids → triglycerides
- promotes
- storage of glucose
- uptake of potassium to cells (hypokalemia can occur)
side effects of insulin
- excess insulin intake
- hypoglycemia
- hypokalemia
- lipohypertrophy
- injecting in same place too often
- stimulates synthesis of adipose tissue
things to monitor when giving insulin
- signs of hypoglycemia
- abrupt onset
- tachycardia
- diphoresis
- shakiness
- gradual onset
- headache
- tremors
- weakness
- abrupt onset
- BG levels
- signs of lipohypertrophy
- potassium levels
- signs of hypokalemia
treating insulin side effects
- hypoglycemia
- check BG to confirm
- give 15-20 g carbs
- 4 oz fruit juice
- 1 Tbsp honey
- glucose tabs per instructions
- for unconscious: parenteral dextrose
- check BG after 15 min
- repeat Tx if necessary
- lipohypertrophy: rotate injection sites
- hypokalemia: give potassium
administration of insulin
- most often given SQ, but also for IV
- SQ
- use insulin syringe marked in units (0.01 mL)
- for suspensions: rotate gently between palms
- when mixing, draw up short-acting first, the long
- do not mix glargine or detemir
- do not give short-acting if cloudy, discolored
- short-acting: make sure carbs available in body at onset and peak times
reasons to adjust dosage of insulin
- caloric intake change
- infection
- exercise
- stress
- growth spurts
- pregnancy
- hospitalization, surgery: sliding scale, short-acting
storing insulin
- in use: room temp for one month
- unopened, single type: refrigerate until expiration date
- premixed in syringe
- 1-2 wks in fridge
- vertical, needles up
- resuspend with gentle motion before admin
pt education for insulin injections
- admin
- draw up Rx amount
- have pt demonstrate
- rotate sites systematically (1 inch apart)
- do not inject cold; keep vial in use at room temp
- s/sx, Tx of hypoglycemia
- medical alert bracelet
contraindications and precautions for insulin
- # of insulins available → pts can usually tolerate one
- contra
- hypersensitivity
- hypoglycemia
- precautions
- renal, hepatic dysfunction
- fever
- thyroid dz
- older adults
interactions with insulin
- ↑ hypoglycemic effects
- sulfonylureas
- meglitinides
- beta blockers
- alcohol
- counteract: ↑ BG level
- thiazide and loop diuretics
- sympathomimetics
- thyroid hormones
- glucocorticoids
- mask hypoglycemia (tachycardia, tremors): beta blockers
amylin mimetics
- Tx of Types 1 and 2 DM
- for pts who can’t control with oral hypoglycemics and insulin
- adjunct with insulin or oral hypoglycemic
- prototype (new class): pramlintide
mechanism of action for amylin mimetics
- mimics peptide hormone amylin from pancreas
- ↓ postprandial BG levels 3 ways
- slows gastric emptying
- inhibits secretion of glucagon
- ↑ feelings of satiety
side effects of emylin mimetics
- hypoglycemia: severe when in combo with insulin
- nausea: mostly in Type 1 DM; ↓ dose can help
- injection site reactions: common